{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:14:46Z","timestamp":1788570886708,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T00:00:00Z","timestamp":1589328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T00:00:00Z","timestamp":1589328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1038\/s10038-020-0772-4","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T03:51:33Z","timestamp":1589341893000},"page":"771-781","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Clinical characterization of patients with leucine-rich repeat kinase 2 genetic variants in Japan"],"prefix":"10.1038","volume":"65","author":[{"given":"Yuanzhe","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyo","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genko","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Kitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Daida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arisa","family":"Hayashida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Ogaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kousuke","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3010-7741","authenticated-orcid":false,"given":"Yoshiaki","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidefumi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Sugeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Miyajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuo","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohisa","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Urabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Takanashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7412-3631","authenticated-orcid":false,"given":"Manabu","family":"Funayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenya","family":"Nishioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,13]]},"reference":[{"key":"772_CR1","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1152\/physrev.00022.2010","volume":"91","author":"O Corti","year":"2011","unstructured":"Corti O, Lesage S, Brice A. What genetics tells us about the causes and mechanisms of Parkinson\u2019s disease. Physiol Rev. 2011;91:1161\u2013218.","journal-title":"Physiol Rev."},{"key":"772_CR2","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/ana.10113","volume":"51","author":"M Funayama","year":"2002","unstructured":"Funayama M, Hasegawa K, Kowa H, Saito M, Tsuji S, Obata F. A new locus for Parkinson\u2019s disease (PARK8) maps to chromosome 12p11.2-q13.1. Ann Neurol. 2002;51:296\u2013301.","journal-title":"Ann Neurol"},{"key":"772_CR3","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"A Zimprich","year":"2004","unstructured":"Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, et al. Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology. Neuron. 2004;44:601\u20137.","journal-title":"Neuron."},{"key":"772_CR4","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","volume":"44","author":"C Paisan-Ruiz","year":"2004","unstructured":"Paisan-Ruiz C, Jain S, Evans EW, Gilks WP, Simon J, van der Brug M, et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson\u2019s disease. Neuron.2004;44:595\u2013600.","journal-title":"Neuron."},{"key":"772_CR5","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S0140-6736(05)17829-5","volume":"365","author":"A Di Fonzo","year":"2005","unstructured":"Di Fonzo A, Rohe CF, Ferreira J, Chien HF, Vacca L, Stocchi F, et al. A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson\u2019s disease. Lancet. 2005;365:412\u20135.","journal-title":"Lancet"},{"key":"772_CR6","first-page":"415","volume":"365","author":"WP Gilks","year":"2005","unstructured":"Gilks WP, Abou-Sleiman PM, Gandhi S, Jain S, Singleton A, Lees AJ, et al. A common LRRK2 mutation in idiopathic Parkinson\u2019s disease. Lancet. 2005;365:415\u20136.","journal-title":"Lancet"},{"key":"772_CR7","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/ana.20484","volume":"57","author":"M Funayama","year":"2005","unstructured":"Funayama M, Hasegawa K, Ohta E, Kawashima N, Komiyama M, Kowa H, et al. An LRRK2 mutation as a cause for the Parkinsonism in the original PARK8 family. Ann Neurol. 2005;57:918\u201321.","journal-title":"Ann Neurol"},{"key":"772_CR8","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/S1474-4422(11)70175-2","volume":"10","author":"OA Ross","year":"2011","unstructured":"Ross OA, Soto-Ortolaza AI, Heckman MG, Aasly JO, Abahuni N, Annesi G, et al. Association of LRRK2 exonic variants with susceptibility to Parkinson\u2019s disease: a case-control study. Lancet Neurol. 2011;10:898\u2013908.","journal-title":"Lancet Neurol"},{"key":"772_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-9-23","volume":"9","author":"R Linhart","year":"2014","unstructured":"Linhart R, Wong SA, Cao J, Tran M, Huynh A, Ardrey C, et al. Vacuolar protein sorting 35 (Vps35) rescues locomotor deficits and shortened lifespan in Drosophila expressing a Parkinson\u2019s disease mutant of Leucine-Rich Repeat Kinase 2 (LRRK2). Mol Neurodegener. 2014;9:23.","journal-title":"Mol Neurodegener"},{"key":"772_CR10","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.parkreldis.2009.11.004","volume":"16","author":"L Correia Guedes","year":"2010","unstructured":"Correia Guedes L, Ferreira JJ, Rosa MM, Coelho M, Bonifati V, Sampaio C. Worldwide frequency of G2019S LRRK2 mutation in Parkinson\u2019s disease: a systematic review. Parkinsonism Relat Disord. 2010;16:237\u201342.","journal-title":"Parkinsonism Relat Disord"},{"key":"772_CR11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.neulet.2005.04.103","volume":"384","author":"EK Tan","year":"2005","unstructured":"Tan EK, Shen H, Tan LC, Farrer M, Yew K, Chua E, et al. The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson\u2019s disease patients. Neurosci Lett. 2005;384:327\u20139.","journal-title":"Neurosci Lett."},{"key":"772_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1017\/S0317167100005783","volume":"34","author":"JW Cho","year":"2007","unstructured":"Cho JW, Kim SY, Park SS, Kim HJ, Ahn TB, Kim JM, et al. The G2019S LRRK2 mutation is rare in Korean patients with Parkinson\u2019s disease. Can J Neurol Sci (Le J Can des Sci Neurol). 2007;34:53\u20135.","journal-title":"Can J Neurol Sci (Le J Can des Sci Neurol)"},{"key":"772_CR13","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/mds.27558","volume":"34","author":"A Kishore","year":"2019","unstructured":"Kishore A, Ashok Kumar Sreelatha A, Sturm M, von-Zweydorf F, Pihlstrom L, Raimondi F, et al. Understanding the role of genetic variability in LRRK2 in Indian population. Mov Disord. 2019;34:496\u2013505.","journal-title":"Mov Disord"},{"key":"772_CR14","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.bbrc.2007.04.006","volume":"357","author":"PA Lewis","year":"2007","unstructured":"Lewis PA, Greggio E, Beilina A, Jain S, Baker A, Cookson MR. The R1441C mutation of LRRK2 disrupts GTP hydrolysis. Biochem Biophys Res Commun. 2007;357:668\u201371.","journal-title":"Biochem Biophys Res Commun"},{"key":"772_CR15","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1016\/j.bbamcr.2013.07.020","volume":"1833","author":"C Manzoni","year":"2013","unstructured":"Manzoni C, Mamais A, Dihanich S, Abeti R, Soutar MPM, Plun-Favreau H, et al. Inhibition of LRRK2 kinase activity stimulates macroautophagy. Biochim Biophys Acta. 2013;1833:2900\u201310.","journal-title":"Biochim Biophys Acta"},{"key":"772_CR16","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1016\/j.yexcr.2008.02.015","volume":"314","author":"N Shin","year":"2008","unstructured":"Shin N, Jeong H, Kwon J, Heo HY, Kwon JJ, Yun HJ, et al. LRRK2 regulates synaptic vesicle endocytosis. Exp Cell Res. 2008;314:2055\u201365.","journal-title":"Exp Cell Res"},{"key":"772_CR17","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","volume":"7","author":"DG Healy","year":"2008","unstructured":"Healy DG, Falchi M, O\u2019Sullivan SS, Bonifati V, Durr A, Bressman S, et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson\u2019s disease: a case-control study. Lancet Neurol 2008;7:583\u201390.","journal-title":"Lancet Neurol"},{"key":"772_CR18","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1001\/jamaneurol.2014.2704","volume":"72","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE, Hazrati LN, Fujioka S, Wszolek ZK, Dickson DW, et al. Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. JAMA Neurol. 2015;72:100\u20135.","journal-title":"JAMA Neurol"},{"key":"772_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-018-0617-y","volume":"6","author":"M Takanashi","year":"2018","unstructured":"Takanashi M, Funayama M, Matsuura E, Yoshino H, Li Y, Tsuyama S, et al. Isolated nigral degeneration without pathological protein aggregation in autopsied brains with LRRK2 p.R1441H homozygous and heterozygous mutations. Acta Neuropathol Commun. 2018;6:105.","journal-title":"Acta Neuropathol Commun"},{"key":"772_CR20","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1136\/jnnp.2006.107904","volume":"78","author":"C Gaig","year":"2007","unstructured":"Gaig C, Marti MJ, Ezquerra M, Rey MJ, Cardozo A, Tolosa E. G2019S LRRK2 mutation causing Parkinson\u2019s disease without Lewy bodies. J Neurol Neurosurg Psychiatry. 2007;78:626\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"772_CR21","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/ana.20791","volume":"59","author":"BI Giasson","year":"2006","unstructured":"Giasson BI, Covy JP, Bonini NM, Hurtig HI, Farrer MJ, Trojanowski JQ, et al. Biochemical and pathological characterization of Lrrk2. Ann Neurol. 2006;59:315\u201322.","journal-title":"Ann Neurol"},{"key":"772_CR22","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.parkreldis.2008.07.010","volume":"15","author":"K Hasegawa","year":"2009","unstructured":"Hasegawa K, Stoessl AJ, Yokoyama T, Kowa H, Wszolek ZK, Yagishita S. Familial parkinsonism: study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes. Parkinsonism Relat Disord. 2009;15:300\u20136.","journal-title":"Parkinsonism Relat Disord"},{"key":"772_CR23","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/mds.22677","volume":"24","author":"JF Marti-Masso","year":"2009","unstructured":"Marti-Masso JF, Ruiz-Martinez J, Bolano MJ, Ruiz I, Gorostidi A, Moreno F, et al. Neuropathology of Parkinson\u2019s disease with the R1441G mutation in LRRK2. Mov Disord. 2009;24:1998\u20132001.","journal-title":"Mov Disord"},{"key":"772_CR24","doi-asserted-by":"publisher","first-page":"2656.e17","DOI":"10.1016\/j.neurobiolaging.2014.05.025","volume":"35","author":"T Hatano","year":"2014","unstructured":"Hatano T, Funayama M, Kubo SI, Mata IF, Oji Y, Mori A, et al. Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson\u2019s disease. Neurobiol Aging 2014;35:2656.e17\u201323.","journal-title":"Neurobiol Aging"},{"key":"772_CR25","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1002\/mds.20886","volume":"21","author":"H Tomiyama","year":"2006","unstructured":"Tomiyama H, Li Y, Funayama M, Hasegawa K, Yoshino H, Kubo S, et al. Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson\u2019s disease patients from 18 countries. Mov Disord. 2006;21:1102\u20138.","journal-title":"Mov Disord"},{"key":"772_CR26","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","volume":"51","author":"WR Gibb","year":"1988","unstructured":"Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 1988;51:745\u201352.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"772_CR27","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature13127","volume":"508","author":"DG MacArthur","year":"2014","unstructured":"MacArthur DG, Manolio TA, Dimmock DP, Rehm HL, Shendure J, Abecasis GR, et al. Guidelines for investigating causality of sequence variants in human disease. Nature. 2014;508:469\u201376.","journal-title":"Nature."},{"key":"772_CR28","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.parkreldis.2008.09.002","volume":"15","author":"IF Mata","year":"2009","unstructured":"Mata IF, Cosentino C, Marca V, Torres L, Mazzetti P, Ortega O, et al. LRRK2 mutations in patients with Parkinson\u2019s disease from Peru and Uruguay. Parkinsonism Relat Disord. 2009;15:370\u20133.","journal-title":"Parkinsonism Relat Disord"},{"key":"772_CR29","unstructured":"Ellard S, Baple EL, Owens M, Eccles DM, Abbs S, Deans ZC, et al. ACGS best practice guidelines for variant classification 2017. Association for Clinical Genetic Science. http:\/\/www.acgs.uk.com\/media\/1059605\/uk_practice_guidelines_for_variant_classification_2017_24_05_17.pdf. 2017."},{"key":"772_CR30","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods 2010;7:248\u20139.","journal-title":"Nat Methods"},{"key":"772_CR31","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/nprot.2009.86","volume":"4","author":"P Kumar","year":"2009","unstructured":"Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4:1073\u201381.","journal-title":"Nat Protoc."},{"key":"772_CR32","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nmeth0810-575","volume":"7","author":"JM Schwarz","year":"2010","unstructured":"Schwarz JM, Rodelsperger C, Schuelke M, Seelow D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods 2010;7:575\u20136.","journal-title":"Nat Methods"},{"key":"772_CR33","doi-asserted-by":"publisher","first-page":"W121","DOI":"10.1093\/nar\/gkz457","volume":"47","author":"M Silk","year":"2019","unstructured":"Silk M, Petrovski S, Ascher DB. MTR-Viewer: identifying regions within genes under purifying selection. Nucleic Acids Res. 2019;47:W121\u20136.","journal-title":"Nucleic Acids Res"},{"key":"772_CR34","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1101\/gr.252601.119","volume":"30","author":"E P\u00e9rez-Palma","year":"2020","unstructured":"P\u00e9rez-Palma E, May P, Iqbal S, Niestroj L-M, Du J, Heyne HO, et al. Identification of pathogenic variant enriched regions across genes and gene families. Genome Res. 2020;30:62\u201371.","journal-title":"Genome Res."},{"key":"772_CR35","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285\u201391.","journal-title":"Nature."},{"key":"772_CR36","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/jhg.2016.12","volume":"61","author":"K Higasa","year":"2016","unstructured":"Higasa K, Miyake N, Yoshimura J, Okamura K, Niihori T, Saitsu H, et al. Human genetic variation database, a reference database of genetic variations in the Japanese population. J Hum Genet. 2016;61:547\u201353.","journal-title":"J Hum Genet"},{"key":"772_CR37","doi-asserted-by":"publisher","first-page":"D551","DOI":"10.1093\/nar\/gkx978","volume":"46","author":"S Tadaka","year":"2018","unstructured":"Tadaka S, Saigusa D, Motoike IN, Inoue J, Aoki Y, Shirota M, et al. jMorp: Japanese multi omics reference panel. Nucleic Acids Res. 2018;46:D551\u20137.","journal-title":"Nucleic Acids Res"},{"key":"772_CR38","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1002\/mds.22682","volume":"24","author":"K Nishioka","year":"2009","unstructured":"Nishioka K, Ross OA, Ishii K, Kachergus JM, Ishiwata K, Kitagawa M, et al. Expanding the clinical phenotype of SNCA duplication carriers. Mov Disord. 2009;24:1811\u20139.","journal-title":"Mov Disord"},{"key":"772_CR39","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.parkreldis.2006.12.001","volume":"13","author":"MJ Farrer","year":"2007","unstructured":"Farrer MJ, Stone JT, Lin CH, Dachsel JC, Hulihan MM, Haugarvoll K, et al. Lrrk2 G2385R is an ancestral risk factor for Parkinson\u2019s disease in Asia. Parkinsonism Relat Disord. 2007;13:89\u201392.","journal-title":"Parkinsonism Relat Disord"},{"key":"772_CR40","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.2169\/internalmedicine.0454-17","volume":"57","author":"H Takeshige","year":"2018","unstructured":"Takeshige H, Nakayama S, Nishioka K, Li Y, Motoi Y, Hattori N. Marked reduction in the striatal dopamine transporter uptake during the early stage of motor symptoms in patients with the MAPT N279K mutation. Intern Med. 2018;57:3015\u20139.","journal-title":"Intern Med"},{"key":"772_CR41","doi-asserted-by":"publisher","first-page":"187.e5","DOI":"10.1016\/j.neurobiolaging.2018.06.036","volume":"72","author":"JR Zhang","year":"2018","unstructured":"Zhang JR, Jin H, Li K, Mao CJ, Yang YP, Wang F, et al. Genetic analysis of LRRK2 in Parkinson\u2019s disease in Han Chinese population. Neurobiol Aging. 2018;72:187.e5\u201310.","journal-title":"Neurobiol Aging."},{"key":"772_CR42","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/ana.20753","volume":"59","author":"K Nishioka","year":"2006","unstructured":"Nishioka K, Hayashi S, Farrer MJ, Singleton AB, Yoshino H, Imai H, et al. Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson\u2019s disease. Ann Neurol. 2006;59:298\u2013309.","journal-title":"Ann Neurol"},{"key":"772_CR43","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1212\/WNL.0000000000000675","volume":"83","author":"F Hentati","year":"2014","unstructured":"Hentati F, Trinh J, Thompson C, Nosova E, Farrer MJ, Aasly JO. LRRK2 Parkinsonism in Tunisia and Norway: a comparative analysis of disease penetrance. Neurology. 2014;83:568\u20139.","journal-title":"Neurology."},{"key":"772_CR44","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1001\/jamaneurol.2017.4019","volume":"75","author":"R Saunders-Pullman","year":"2018","unstructured":"Saunders-Pullman R, Mirelman A, Alcalay RN, Wang C, Ortega RA, Raymond D, et al. Progression in the LRRK2-associated Parkinson disease population. JAMA Neurol. 2018;75:312\u20139.","journal-title":"JAMA Neurol"},{"key":"772_CR45","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1093\/hmg\/ddq081","volume":"19","author":"S Lesage","year":"2010","unstructured":"Lesage S, Patin E, Condroyer C, Leutenegger AL, Lohmann E, Giladi N, et al. Parkinson\u2019s disease-related LRRK2 G2019S mutation results from independent mutational events in humans. Hum Mol Genet. 2010;19:1998\u20132004.","journal-title":"Hum Mol Genet"},{"key":"772_CR46","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1069675","volume":"296","author":"J Oeppen","year":"2002","unstructured":"Oeppen J, Vaupel JW. Broken limits to life expectancy. Science 2002;296:1029\u201331.","journal-title":"Science"},{"key":"772_CR47","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/mds.27193","volume":"32","author":"SA Schneider","year":"2017","unstructured":"Schneider SA, Alcalay RN. Neuropathology of genetic synucleinopathies with Parkinsonism: review of the literature. Mov Disord. 2017;32:1504\u201323.","journal-title":"Mov Disord."},{"key":"772_CR48","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/S1474-4422(16)30203-4","volume":"15","author":"J Trinh","year":"2016","unstructured":"Trinh J, Gustavsson EK, Vilarino-Guell C, Bortnick S, Latourelle J, McKenzie MB, et al. DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser Parkinsonism: a genome-wide linkage and association study. Lancet Neurol. 2016;15:1248\u201356.","journal-title":"Lancet Neurol"},{"key":"772_CR49","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1042\/BST20160264","volume":"45","author":"MS Islam","year":"2017","unstructured":"Islam MS, Moore DJ. Mechanisms of LRRK2-dependent neurodegeneration: role of enzymatic activity and protein aggregation. Biochem Soc Trans. 2017;45:163\u201372.","journal-title":"Biochem Soc Trans"}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s10038-020-0772-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-020-0772-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-020-0772-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T14:03:18Z","timestamp":1650204198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s10038-020-0772-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,13]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["772"],"URL":"https:\/\/doi.org\/10.1038\/s10038-020-0772-4","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,13]]},"assertion":[{"value":"27 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}